Combs DW - Search Results

1

Synthesis and evaluation of nonpeptide substituted spirobenzazepines as potent vasopressin antagonists.

Xiang MA, Chen RH, Demarest KT, Gunnet J, Look R, Hageman W, Murray WV, Combs DW, Rybczynski PJ, Patel M. Xiang MA, et al. Among authors: combs dw. Bioorg Med Chem Lett. 2004 Jun 21;14(12):3143-6. doi: 10.1016/j.bmcl.2004.04.016. Bioorg Med Chem Lett. 2004. PMID: 15149662

2

Benzoxazinones as PPARgamma agonists. part 1: SAR of three aromatic regions.

Rybczynski PJ, Zeck RE, Combs DW, Turchi I, Burris TP, Xu JZ, Yang M, Demarest KT. Rybczynski PJ, et al. Among authors: combs dw. Bioorg Med Chem Lett. 2003 Jul 21;13(14):2359-62. doi: 10.1016/s0960-894x(03)00401-3. Bioorg Med Chem Lett. 2003. PMID: 12824034

3

Synthesis and evaluation of spirobenzazepines as potent vasopressin receptor antagonists.

Xiang MA, Chen RH, Demarest KT, Gunnet J, Look R, Hageman W, Murray WV, Combs DW, Patel M. Xiang MA, et al. Among authors: combs dw. Bioorg Med Chem Lett. 2004 Jun 7;14(11):2987-9. doi: 10.1016/j.bmcl.2004.02.103. Bioorg Med Chem Lett. 2004. PMID: 15125974

4

Synthesis and SAR of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives as non-peptidic motilin receptor antagonists.

Johnson SG, Gunnet JW, Moore JB, Miller W, Wines P, Rivero RA, Combs D, Demarest KT. Johnson SG, et al. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3362-6. doi: 10.1016/j.bmcl.2006.04.017. Epub 2006 May 2. Bioorg Med Chem Lett. 2006. PMID: 16650762

5

Benzoxazinones as PPARgamma agonists. 2. SAR of the amide substituent and in vivo results in a type 2 diabetes model.

Rybczynski PJ, Zeck RE, Dudash J Jr, Combs DW, Burris TP, Yang M, Osborne MC, Chen X, Demarest KT. Rybczynski PJ, et al. Among authors: combs dw. J Med Chem. 2004 Jan 1;47(1):196-209. doi: 10.1021/jm0301888. J Med Chem. 2004. PMID: 14695833

6

Nonsteroidal progesterone receptor ligands. 2. High-affinity ligands with selectivity for bone cell progesterone receptors.

Combs DW, Reese K, Cornelius LA, Gunnet JW, Cryan EV, Granger KS, Jordan JJ, Demarest KT. Combs DW, et al. J Med Chem. 1995 Dec 8;38(25):4880-4. doi: 10.1021/jm00025a004. J Med Chem. 1995. PMID: 8523400

7

gamma-Aminobutyrate-A receptor modulation by 3-aryl-1-(arylsulfonyl)- 1,4,5,6-tetrahydropyridazines.

Rybczynski PJ, Combs DW, Jacobs K, Shank RP, Dubinsky B. Rybczynski PJ, et al. Among authors: combs dw. J Med Chem. 1999 Jul 1;42(13):2403-8. doi: 10.1021/jm9805889. J Med Chem. 1999. PMID: 10395481

8

Discovery of the first non-peptide antagonist of the motilin receptor.

Beavers MP, Gunnet JW, Hageman W, Miller W, Moore JB, Zhou L, Chen RH, Xiang A, Urbanski M, Combs DW, Mayo KH, Demarest KT. Beavers MP, et al. Among authors: combs dw. Drug Des Discov. 2001;17(3):243-51. Drug Des Discov. 2001. PMID: 11469754

9

Nonsteroidal progesterone receptor ligands with unprecedented receptor selectivity.

Palmer S, Campen CA, Allan GF, Rybczynski P, Haynes-Johnson D, Hutchins A, Kraft P, Kiddoe M, Lai M, Lombardi E, Pedersen P, Hodgen G, Combs DW. Palmer S, et al. Among authors: combs dw. J Steroid Biochem Mol Biol. 2000 Dec 1;75(1):33-42. doi: 10.1016/s0960-0760(00)00134-5. J Steroid Biochem Mol Biol. 2000. PMID: 11179906

10

Induction of a novel conformation in the progesterone receptor by ZK299 involves a defined region of the carboxyl-terminal tail.

Allan GF, Lombardi E, Haynes-Johnson D, Palmer S, Kiddoe M, Kraft P, Campen C, Rybczynski P, Combs DW, Phillips A. Allan GF, et al. Among authors: combs dw. Mol Endocrinol. 1996 Oct;10(10):1206-13. doi: 10.1210/mend.10.10.9121488. Mol Endocrinol. 1996. PMID: 9121488

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters